IFNγ-activated dermal lymphatic vessels inhibit cytotoxic T cells in melanoma and inflamed skin
Year: 2018
Type: article
Abstract: Mechanisms of immune suppression in peripheral tissues counteract protective immunity to prevent immunopathology and are coopted by tumors for immune evasion. While lymphatic vessels facilitate T cell priming, they also exert immune suppressive effects in lymph nodes at steady-state. Therefore, we hypothesized that peripheral lymphatic vessels acquire suppressive mechanisms to limit local effector CD8+ T cell accumulation in murine skin. We demonstrate that nonhematopoietic PD-L1 is largely expressed by lymphatic and blood endothelial cells and limits CD8+ T cell accumulation in tumor microenvironments. IFNγ produced by tissue-infiltrating, antigen-specific CD8+ T cells, which are in close proximity to tumor-associated lymphatic vessels, is sufficient to induce lymphatic vessel PD-L1 expression. Disruption of IFNγ-dependent crosstalk through lymphatic-specific loss of IFNγR boosts T cell accumulation in infected and malignant skin leading to increased viral pathology and tumor control, respectively. Consequently, we identify IFNγR as an immunological switch in lymphatic vessels that balances protective immunity and immunopathology leading to adaptive immune resistance in melanoma.
DOI: 10.1084/jem.20180654
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Funders: U.S. Department of Defense, Cancer Research Institute, V Foundation for Cancer Research, Melanoma Research Alliance, Oregon Health and Science University, Vetenskapsrådet, National Institutes of Health, Japan Society for the Promotion of Science, National Cancer Institute, DOD Peer Reviewed Cancer Research Program
Awards: Tissue imaging-based immune profiling of head and neck cancer, G1581679921, G2043903442, G2155324745, G2800195642, G4119534169, G4297529078, Training in the Molecular Basis of Skin/Mucosa Pathobiology, G5850682332, G6803870786, MELANOMA-ASSOCIATED LYMPHANGIOGENESIS, IMMUNE SUPPRESSION, AND RESPONSE TO TARGETED THERAPY, G8471844906, G9000044262, G9000084039, G9000156400
OpenAlex ID: W2899435407
